HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The "motor complication syndrome" in rats with 6-OHDA lesions treated chronically with L-DOPA: relation to dose and route of administration.

Abstract
L-DOPA-induced motor complications can be modelled in rats with 6-hydroxydopamine (6-OHDA) lesions by chronic injections of L-DOPA. We have compared the sensitisation and duration of rotational responses, and the occurrence of dose-failure episodes and abnormal involuntary movements (AIMs) in 6-OHDA-lesioned rats with regard to the dose and route of administration of L-DOPA. Rats were treated with either low (6mg/kg) or high (25mg/kg) doses of L-DOPA twice daily for 21 days whereas control animals received injections of either saline or bromocriptine (2.5mg/kg). A dose-dependent and gradual development of AIMs and contralateral turning was observed in rats treated chronically with l-DOPA. Rats treated with bromocriptine exhibited rotational sensitisation but no AIMs. A shortening of motor response duration was not seen in any of the drug-treated groups. In contrast, dose-failure episodes occurred frequently in both L-DOPA- and bromocriptine-treated animals. Changing the route of L-DOPA administration from intraperitoneal to subcutaneous completely abolished failures in motor response without affecting the development of dyskinesia. Based on the hypothesis that higher doses of L-DOPA may be toxic to dopaminoceptive structures, we compared the total number of neurons and the levels of activated microglia in the striatum. No signs of neurodegenerative changes could be seen in any of the treatment groups. In conclusion, both body AIMs and rotations were dose-dependently evoked by L-DOPA. Only AIMs, however, provided a specific measure of dyskinesia since rotations also were induced by bromocriptine, a drug with low dyskinesiogenic potential. Dose-failure episodes were not specific to L-DOPA treatment and could be attributed to erratic drug absorption from the peritoneal route.
AuthorsHanna S Lindgren, Daniella Rylander, K Elisabet Ohlin, Martin Lundblad, M Angela Cenci
JournalBehavioural brain research (Behav Brain Res) Vol. 177 Issue 1 Pg. 150-9 (Feb 12 2007) ISSN: 0166-4328 [Print] Netherlands
PMID17157933 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Dopamine Agents
  • Lipopolysaccharides
  • Bromocriptine
  • Levodopa
  • Oxidopamine
  • Tyrosine 3-Monooxygenase
Topics
  • Analysis of Variance
  • Animals
  • Brain Injuries (chemically induced, complications)
  • Bromocriptine (administration & dosage)
  • Cell Count
  • Dopamine Agents (administration & dosage, blood)
  • Dose-Response Relationship, Drug
  • Drug Administration Routes
  • Female
  • Immunohistochemistry (methods)
  • Levodopa (administration & dosage, blood)
  • Lipopolysaccharides (administration & dosage)
  • Movement Disorders (drug therapy, etiology)
  • Oxidopamine
  • Rats
  • Rats, Sprague-Dawley
  • Rotarod Performance Test (methods)
  • Time Factors
  • Tyrosine 3-Monooxygenase (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: